Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | MGAM | O43451 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | SI | P14410 | 1/20 | 0.33 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29779768 | 0.79 | OXER1 (0.33) | — | |
| SCHEMBL2946746 | 0.75 | TSHR (0.53) | TSHRHSD17B10MGAMGAASI | |
| SCHEMBL3783491 | 0.74 | MGAM (0.33) | TSHRMGAMGAASIMGAM2 | |
| SCHEMBL5411373 | 0.72 | — | — | |
| SCHEMBL1495932 | 0.71 | CA1 (0.31) | — | |
| SCHEMBL26186915 | 0.71 | TSHR (0.48) | TSHRHSD17B10MGAMGAASI | |
| SCHEMBL711034 | 0.69 | — | — | |
| SCHEMBL2946724 | 0.68 | GAA (0.54) | TSHRHSD17B10MGAMGAASI | |
| SCHEMBL17674024 | 0.68 | TSHR (0.32) | TSHRHSD17B10MGAMGAASI | |
| SCHEMBL4531676 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8343893-B2 | Substituted enaminocarbonyl compounds | BAYER CROPSCIENCE AG (DE) | 2013-01-01 | — | — | US | disclosed |
| US-20100324103-A1 | Substituted Enaminocarbonyl Compounds | BAYER CROPSCIENCE AG (DE) | 2010-12-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100324103-A1 | Substituted Enaminocarbonyl Compounds | DDT, L3MBTL3, L3MBTL4 | TSHR 1772/4885HSD17B10 2729/4885MGAM 2486/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.